Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-07

Clinical Trial Update: Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral famciclovir 125 mg to aciclovir 200 mg in active recurrent genital herpes completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aciclovir (acyclovir)
  • Famciclovir (famciclovir)

Snippet

Sponsor: EMS | Conditions: GENITAL HERPES | Phase 3 | Status: COMPLETED | Results posted: 2015-07-07